We assessed the ability of two screening protocols to detect varying degrees of hyperglycaemia in pregnancy and to compare fetal outcome in those found to have normal and abnormal glucose metabolism by either protocol. 493 pregnant women were identified by one of two screening protocols to be at risk of hyperglycaemia in pregnancy. Pregnancy complications, induction of labour, method of delivery, birth weight, incidence of congenital anomalies and neonatal complications were assessed; there were no significant differences between those with normal and abnormal glucose metabolism detected by either protocol apart from a significant linear trend for the incidence oflarge for gestational infants with increasing hyperglycaemia in both groups. Protocol B was as effective in detecting new hyperglycaemia in pregnancy as Protocol A. It involved the use of a breakfast meal profile in the initial assessment of those screened positive, reducing the need for glucose tolerance tests in the vast majority of cases. In the population studied, hyperglycaemia in pregnancy was not associated with adverse fetal outcome.
INTRODUCTION
Hyperglycaemia in pregnancy is a term which can be used to encompass a large spectrum of disordered carbohydrate metabolism, which ranges from the upper end of normality to overt clinical diabetes. Pregnancy has important effects on carbohydrate metabolism, exerted mainly through a decrease in insulin sensitivity, which results in higher post prandial blood glucose levels. In pregnant women with a normal pancreatic B cell reserve, insulin secretion is increased in response to this decreased sensitivity, and glucose homeostasis is restored.' Pregnancy can thus unmask a defect in carbohydrate metabolism in those who have a limited B cell reserve, resulting in hyperglycaemia of varying severity. Even in present day obstetric practice, hyperglycaemia in pregnancy presents a major risk to the fetus, the effects of which extend from fetal life through neonatal life into adolescence. Hyperglycaemia in pregnancy may damage fetal pancreatic B cells, increasing susceptibility to carbohydrate intolerance in the future. 2'3 The aim of screening mothers for evidence of abnormal carbohydrate metabolism in pregnancy is to minimise or eliminate these risks to the fetus. There are a number of screening tests in current use, with no consensus view as to the best method. In the UK the methods more commonly used include clinical risk factors, glycosuria, random plasma glucose and glycosylated haemoglobin. Each of these methods when used alone has relatively low sensitivity and specificity. The aim of this study was to look at fetal outcome in pregnancies complicated by varying degrees of hyperglycaemia detected by two screening protocols between 1992 and 1996. Those mothers identified by the two screening protocols to have hyperglycaemia in pregnancy, went on to have either a 75 g oral glucose tolerance test (OGTT). (1992) (1993) (1994) or a 300 kcal breakfast meal test (1994) (1995) (1996) (Table IV) . Fetal outcomes for the two groups are shown in Table V . There was no increase in perinatal mortality or incidence of birth trauma in babies born to mothers with abnormal tests in either group. There were no statistically significant differences in birth weight or gestational age at delivery in babies born to mothers with abnormal tests in either group. There was a significant linear trend (p <0.001) in the incidence of large for gestational age babies with increasing hyperglycaemia in both groups. Most babies with congenital abnormalities, major and minor, in the study group were born to mothers with normal GTT or breakfast meal test results. Mean APGAR scores at one and five minutes were similar in those babies born to mothers with normal and abnormal GTT and breakfast meal test results. 
The incidence of neonatal complications known be more common in the infant of the diabetic mother was assessed. There was no evidence to suggest that any of these complications were more common in those babies born to mothers with hyperglycaemia in pregnancy. Most babies who required admission to the special care baby unit were born to mothers with normal GTT or breakfast meal test results. During the four year period studied, only six cases of gestational diabetes were discovered; three by the GTT and three by the breakfast meal test. Five of these patients were treated with insulin, and all stopped insulin post-delivery. They were all seen subsequently at the Royal Victoria Hospital. Clinical records were traced for four ofthe five patients, all of whom now have Type 1 diabetes and are on insulin treatment.
DISCUSSION
The aim of screening mothers for evidence of abnormal carbohydrate metabolism in pregnancy is to detect the problem at an early stage and so prevent any adverse fetal outcome. The only meaningful criteria by which to judge the importance of the state of glucose metabolism in pregnancy are fetal outcome, either in the short or longer term, or the long term maternal outcome.6
Various indices of fetal outcome have been used to assess the effect of hyperglycaemia in pregnancy. Because of the general decline in perinatal mortality rates in recent years, this index of fetal outcome can no longer be used as a practical outcome measure. Therefore other short term pregnancy outcomes have become more important in assessing the effect, if any, of maternal hyperglycaemia. 
